Are tigecycline generics more affordable than brand name options?

Tigecycline generics cost substantially less than the original brand product. Manufacturers introduced generic versions after the primary patent expired, and current average wholesale prices reflect that drop.

Why do generic prices vary so much?
Prices range from roughly $20 to $120 per vial depending on the supplier and volume purchased by hospitals. Smaller or newer entrants often price lower to gain market share, while established generic firms hold steadier prices.

Which companies make the generic versions?
Mylan, Fresenius Kabi, and Teva are the main suppliers. Each uses the same active ingredient but sources it from different API plants, which can create minor differences in manufacturing cost and therefore list price.

When did the first generic reach the market?
The first generic approval came in 2015, shortly after the brand exclusivity period ended. Additional approvals followed quickly, increasing competition and further lowering prices.

Do hospitals see bigger savings than retail pharmacies?
Hospitals and group purchasing organizations negotiate volume contracts that can cut the per-vial cost by another 30-50 percent compared with published wholesale prices. Retail pharmacies rarely stock tigecycline, so the comparison applies mainly to institutional buyers.

Can a patient request the generic at the pharmacy?
Most pharmacies will dispense the generic automatically when available, but tigecycline is almost always administered in hospitals, so the decision rests with the facility's formulary committee rather than the patient.

How do insurance plans treat brand versus generic tigecycline?
Plans typically place the brand on a higher tier or require prior authorization, while the generic sits on the lowest tier with minimal or no copay for covered patients.